Sugi Predict

Sugi Predict / Compounds / SCHEMBL4474947

SCHEMBL4474947

SCHEMBL4474947

O=C(Cc1ccccc1)N1CCN(Cc2ccc(-c3ccccc3Cl)cc2)C[C@H]1Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.50
▸ DPP7 Q9UHL4 1/20 0.50
▸ CA1 P00915 4/20 0.49
▸ CA2 P00918 4/20 0.49
▸ CA4 P22748 4/20 0.49
▸ CA9 Q16790 4/20 0.49
▸ CNR2 P34972 1/20 0.48
▸ MC4R P32245 2/20 0.47
▸ MC3R P41968 2/20 0.47
▸ MC1R Q01726 2/20 0.47
▸ ROCK1 Q13464 1/20 0.45
▸ ERAP2 Q6P179 1/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ S1PR5 Q9H228 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4475442 1.00 DPP4 (0.50) DPP4DPP7CA1CA2CA4
SCHEMBL4474944 1.00 DPP4 (0.50) DPP4DPP7CA1CA2CA4
SCHEMBL4467575 0.88 CA1 (0.50) DPP4DPP7CA1CA2CA4
SCHEMBL4468592 0.88 CA1 (0.50) DPP4DPP7CA1CA2CA4
SCHEMBL13708840 0.88 CNR2 (0.53) DPP4DPP7CA1CA2CA4
SCHEMBL4475466 0.88 CNR2 (0.53) DPP4DPP7CA1CA2CA4
SCHEMBL4475464 0.88 CNR2 (0.53) DPP4DPP7CA1CA2CA4
SCHEMBL4471690 0.88 CA1 (0.62) DPP4DPP7CA1CA2CA4
SCHEMBL4471692 0.88 CA1 (0.62) DPP4DPP7CA1CA2CA4
SCHEMBL4476835 0.88 CA1 (0.62) DPP4DPP7CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595397-B2 Compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-29 — — US disclosed
US-7595397-B2 Compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-29 — — US disclosed
US-7595397-B2 Compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-29 — — US disclosed
US-20070191340-A1 Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-08-16 — — US disclosed
US-20070191340-A1 Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-08-16 — — US disclosed
US-20070191340-A1 Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-08-16 — — US disclosed
WO-2007070760-A2 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191340-A1 Compounds Which Modulate The CB2 Receptor CNR1, CNR2, ARRB1 DPP4 4538/4885DPP7 4519/4885CA1 3294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.